DIVIS LAB Share Price Target 2022, 2023, 2024, 2025, And 2030: Hi, good morning everyone hopes you all are fine there. So,
today we are here to give you the share price target for Divis Lab which is known as
Divi’s Laboratories Limited for upcoming years to come. Its Headquartered in
Telangana, India.
We try to predict the share price target for Divis Lab on the
basis of their technical analysis chart, their past year's quarterly and annual
reports. Divis Lab is India’s second most popular and valuable pharmaceutical
company. The present CEO of Divis Lab is Mr. Satchandra Kiran Divi.
DIVIS LAB Share Price Target 2022, 2023, 2024, 2025, And 2030
Divi’s Laboratories Limited is an Indian multinational
company that deals in the pharmaceutical sector. They mainly involve in the
production of APIS which have highly dependent on the worldwide market. They have
more than 350 Scientists who work there for producing life-saving at a viable
price.
Technical Analysis Of DIVIS LAB
We tell you how the shares price of Divis Lab were
performed in past years and by using the number of different tools we will try to
form technical analysis for future years to Come which you are also, here to see it
below.
As we all can see in a chart, Divis Lab follows a cycle range
pattern and they also take good support on the Fibonacci retracement. In laymen
language, we can see that even their stock price has fallen for a while but its
short-term trend is in the positive direction and in an uptrend. Divis lab long-term trend is also in a positive direction and they are also in an uptrend.
Share Price Target For DIVIS LAB
We are trying to predict a possible target which the shares of Divis Lab can cross in upcoming years. Our prediction is based upon different tools
and terms which include Fibonacci retracement, support, and resistance. So, here
we go with your possible targets for the upcoming years which are attached below.
Year | Target Of Divi's Lab |
---|---|
2022(Target-1) | Rs.6042 |
(Target-2) | Rs.6469 |
2023(Target-1) | Rs.7274 |
(Target-2) | Rs.8507 |
2024(Target-1) | Rs.9502 |
(Target-2) | Rs.10568 |
2025(Target-1) | Rs.11824 |
(Target-2) | Rs.13364 |
2030(Target-1) | Rs.18034 |
(Target-2) | Rs.27933 |
DIVIS LAB Share Price Target For 2022
When we read the technical charts we predict two possible
targets which the share of Divis Lab can attain in the year 2022 first is around
Rs.6042 and after attaining these values share price will go down for a while
but they will again move in an uptrend because of their product demand in the
marked we will predict second possible target which they can cross is
around Rs.6469.
DIVIS LAB Share Price Target For 2023
In the year 2023, we again going to predict two possible the target for the share price of Divis Lab which they can attain easily because of
their research developed a product that is going to be a life-saving product for
mankind so, we predict the first possible target is Rs.7274 and the second possible
target is around Rs.8507.
DIVIS LAB Share Price Target For 2024
As the charts show they will give good returns in future
years to come so, here we predict the first target for the year 2024 is about
Rs.9502 and the second possible target which they can attain after showing some the downtrend is about Rs.10568.
DIVIS LAB Share Price Target For 2025
As we read the chart for the year 2025, they will move in an
uptrend which helps the share price of Divis Lab to increase their price. So, we
predict the first target which they can get in the year 2025 is about Rs.11824, and second, the possible target which they can cross in the same year is about
Rs.13364.
DIVIS LAB Share Price Target For 2030
Till the end of this decade, Divis Lab will be the highest
revenue-generating company in the pharmaceutical sector in South Asian
Countries which include china too. So we predict the first possible target which
they can attain in the year 2030 is around Rs.18,034 and the second possible target
which they can cross till the end of this decade is around Rs.27,933.
Quarterly Report Analysis For DIVIS LAB
As the data are given at ticker.finology.in we are telling you
about company last year performance that
how they perform in every quarter of last year if you any mismatch of data in
from the official site of Divis Lab we're not responsible for it.
As the data in a chart is available, in the first quarter of the fiscal year 2020 company made net sales of around Rs.1,376.24cr. and they make out of it around Rs.391.80cr.
in the second quarter of the same financial year 2020, they make net sales of
Rs.1,709.96 and make a profit of around Rs.492.25cr. same in the third quarter of the financial year 2020 they make sales of Rs.1,713.78cr. and profit of around
Rs.513.30cr. which is pretty much higher than other quarters which is the reason
for their deals with other pharmaceutical companies for their research-based
product.
In the last quarter of 2020, they make net sales of around
Rs.1,656.48 and make a profit out of it around Rs.461.24cr. and in the first
quarter of the financial year, 2021 company made net sales of about Rs.1,718.39cr.
and make a profit from it of around Rs.487.93cr.
Annual Report Analysis for DIVIS LAB
As the data are given at ticker.finology.in we are telling you
about company last year performance that
how they perform in every quarter of last year if you any mismatch of data in
from the official site of Divis Lab we're not responsible for it.
In the year 2017, the company made net sales of around
Rs.4,023.85cr. and make a profit out of it of about Rs.1,053.27 in that year
Divis Lab develops its infrastructure for research-based projects. In the
following year 2018, they make net sales of Rs.3,815.94cr. and make a profit off it
around Rs.869.58cr. which is pretty much lower than other years as concerned
because of the earlier reason which I mentioned in the year 2017. In the next
year which is 2019, they make sales of about Rs.4,879.66cr. and make a profit off
it around Rs.1,332.65cr.
In the year 2020, they make sales of Rs.5,310.57, and a profit
of around Rs.1,372.71 which is higher than the last 3 years which is the result of their
investment in a research-based project. in the year 2021, they make sales of around
Rs.6,798.61cr. and make a profit of about Rs.1,954.72 as we can see there from
last two years they make good revenue that why I said earlier that till the end
of this decade Divis lab will emerge as the highest revenue generating company in
India.
Conclusion
In this artical, We have done a detailed analysis of the Divis Lab.
We were tried to include every aspect in our artical that is really essential
to know before investing in any specific company shares.
Before ending this artical, I am going to tell you some
strengths which help Divis Lab to emerge as the highest revenue-generating company
at the end of this decade.
1. Strong financial condition.
2. Socially active.
3. Brand value.
4. Advanced knowledge management.
5. More than 300 scientists working on research-based projects.
2. Socially active.
3. Brand value.
4. Advanced knowledge management.
5. More than 300 scientists working on research-based projects.
If you are having any doubts or questions
regarding this artical, you can ask me in a comment section and share this
artical with your friends and family members which help them to invest in the
right companies and also us to reach millions of people.
Post a Comment